This review summarizes the current understanding of the mechanisms underlying cytopenias in CLD and discusses available therapeutic strategies, including platelet transfusion, spleen-targeted interventions, thrombopoietin-based treatments, thrombopoietin receptor agonists, and granulocyte colony-stimulating factor. Here, THPO is linked to congenital secretory chloride diarrhea 1.